News

Chewy Inc. Reports Strong Q2 FY2025 Earnings and Growth Highlights

Chewy Inc. Reports Strong Q2 FY2025 Earnings and Growth Highlights

Chewy Inc. Reflects on Q2 FY2025 Performance

Chewy Inc. (NYSE: CHWY) recently shared its impressive earnings results for the second quarter of fiscal year 2025. The company reported adjusted earnings of 33 cents per share, significantly higher than the consensus estimate of 14 cents, as well as its expected range of 30-35 cents. This performance exemplifies Chewy's ongoing growth and commitment to its customers.

Record Sales and Customer Growth

Chewy's net sales reached a remarkable $3.1 billion for Q2, marking nearly a 9% increase year-over-year. This growth positioned Chewy well against the industry's low to mid-single-digit growth backdrop, highlighting its share-gaining strategy. A standout factor in this success was the Autoship program, which generated $2.58 billion in sales—83% of the total Q2 net sales, achieving new record levels for the company. The growth in Autoship customer sales was notably strong, exceeding 15% compared to the previous year.

Continuing Customer Engagement

As of the end of Q2, Chewy boasts 20.9 million active customers, reflecting an annual growth rate of 4.5%. The company observed a marked improvement in the quality of its new customers, with a stronger cohort performance relative to the previous fiscal year. Chewy is also expanding its customers' spending, with an average spend per active customer reaching $591, a 4.6% year-over-year growth.

Profitability and Strategic Initiatives

Chewy's gross margin rose to 30.4%, showing robust expansion both sequentially and year-over-year. Significant contributors to this margin improvement included the growth of the sponsored advertisements business and a favorable mix towards premium product categories. The company's focus on maintaining rational pricing was critical, allowing for sustained profitability.

Earnings and Shareholder Returns

In terms of profitability, Chewy generated $83.3 million in adjusted EBITDA during the quarter, resulting in a 5.9% EBITDA margin, marking an increase from the previous year. Furthermore, Chewy produced nearly $106 million in free cash flow, demonstrating its financial health. This enabled the company to return approximately $125 million to shareholders through share repurchases, reinforcing its commitment to delivering value.

Innovation: New Product Launches

Chewy is not resting on its laurels; the company recently launched its new private brand, Get Real, which offers healthy fresh dog food options. This initiative reflects the growing trend toward premiumization in pet food, targeting consumers who want the best for their pets. Get Real's initial reception has been positive, indicating strong potential for future sales growth.

Adoption of Chewy's Membership Program

The Chewy membership program demonstrates promising results. As of July, about 3% of total monthly sales were generated from Chewy members, who tend to exhibit higher spending and frequency of purchases. The program is designed to provide exclusive benefits like free shipping, rewards, and unique member offers. Chewy plans to expand this initiative further in the upcoming fiscal year.

Market Outlook

Looking ahead, Chewy expects to maintain its sales momentum with net sales projected between $12.5 billion and $12.6 billion for the full year. The company anticipates continued growth in its adjusted EBITDA margins, supported by enhancements in gross margin, and the strategic expansion of its product lines and membership programs.

Conclusion

Chewy's performance in Q2 FY2025 highlights its strength in the pet retail market. With solid earnings growth, increasing customer engagement, and innovative product offerings, Chewy is well-positioned for sustainable long-term success.

Frequently Asked Questions

What were Chewy's earnings per share for Q2 FY2025?

Chewy reported adjusted earnings of 33 cents per share for the second quarter of fiscal year 2025.

How much did Chewy's net sales grow in Q2 FY2025?

Chewy's net sales grew by nearly 9% year-over-year, totaling $3.1 billion for the quarter.

What percentage of Chewy's sales came from Autoship customers?

Sales from Autoship customers represented 83% of Chewy's net sales in Q2 FY2025, amounting to $2.58 billion.

What new product did Chewy launch recently?

Chewy launched Get Real, a private brand offering healthy fresh dog food options.

What is the company's outlook for full-year sales?

Chewy projects its full-year net sales to be between $12.5 billion and $12.6 billion for fiscal year 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 18

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 19

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 13

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 18

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Home Buying: Unmasking All the Real Budget Costs

Updated Category News Views 10

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 21

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 6

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 32

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 6

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading

Top 5 Most Recently Viewed Articles

WiMi Hologram Cloud's Blockchain-Driven Cloud Service Innovation

Updated Category News Views 140

WiMi Hologram Cloud's Blockchain-Driven Service Innovation WiMi Hologram Cloud Inc. (NASDAQ: WiMi), a premier global provider of Hologram Augmented Reality (AR) Technology, has unveiled a transformative Cloud Service Trust Interaction Framework leveraging Blockchain Technology. This innovative framework is designed to improve service credibility while optimizing user...

Continue Reading
Delicious Bagel Chips Now Available Online from Eccentric Bagel

Updated Category News Views 227

Welcome to Eccentric Bagel's Online Shop Prepare to treat yourself to something special from The Eccentric Bagel, where our innovative flavor creations are now available online for everyone to enjoy. We’re excited to introduce our online store, giving you easy access to our one-of-a-kind bagel chips, which can be shipped to customers all over the country. This is a...

Continue Reading
Understanding Hut 8 Corp's Market Dynamics and Trends

Updated Category News Views 165

Insights into Hut 8 Corp's Market Support Hut 8 Corp (NYSE:HUT) has recently seen notable changes in its short interest, raising questions about its market support. The short interest, representing shares sold short, has grown by 5.45% since the latest report. Currently, there are approximately 17.39 million shares sold short, which constitutes around 17.8% of all shares...

Continue Reading
ViCentra Introduces Smartphone-Controlled Diabetes Solution by 2026

Updated Category News Views 213

ViCentra's Upcoming Smartphone-Based Therapy for Diabetes ViCentra, renowned for its innovative Kaleido insulin patch pump, is set to revolutionize diabetes management with the upcoming launch of its smartphone-controlled closed loop therapy. The exciting development is expected to debut in early 2026, promising a more user-friendly approach to insulin delivery and...

Continue Reading
Short Interest Trends and Market Sentiment for Linde PLC

Updated Category News Views 111

Understanding Short Interest for Linde PLC Linde PLC (NYSE: LIN) has shown notable shifts in its short interest recently. The short percent of float for Linde has decreased by 4.59%, indicating fresh dynamics in how traders perceive this leading industrial gas company. Current reports show that there are approximately 4.90 million shares sold short, which represents 1.04%...

Continue Reading